A recent revision was made in the Use of Antiretroviral Therapy for Adults and Adolescents Guidelines. Delavirdine is added to nevirapine as an acceptable or equivalent non-nucleoside reverse transcriptase inhibitor, in the Alternative Options category. In addition, invirase plus two nucleoside reverse transcriptase inhibitors, are demoted from the Alternative Options category.
|Original language||English (US)|
|Number of pages||1|
|Journal||The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service|
|State||Published - May 1998|
ASJC Scopus subject areas